Eleven Therapeutics

Eleven Therapeutics

Verified
Research firm that unleashes the power of RNAi technology that helps to create precise and durable therapeutics

Launch date
Employees
Ownership
Market cap
-
Net debt
-
Firm valuation
$88—132m (Dealroom.co estimates Aug 2022.)
Tel Aviv-Yafo Tel Aviv District (HQ)
  • Edit
DateInvestorsAmountRound
$2mSeed
*
$3.9mGrant
Not yet verified
*
£300kGrant
Not yet verified
*
$22mSeed
*
N/AGrant
Total Funding$24m

Recent News about Eleven Therapeutics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.